Literature DB >> 15080618

An analytical method for the analysis of tulathromycin, an equilibrating triamilide, in bovine and porcine plasma and lung.

Diana Gáler1, Scott Hessong, Brian Beato, James Risk, Philip Inskeep, Chandralal Weerasinghe, Richard P Schneider, Connie Langer, Jennifer LaPerle, Donald Renouf, Andrew Bessire, Eden Español, Robert Rafka, Colman Ragan, Wayne Boettner, Trisha Murphy, David Keller, Hafid Benchaoui, Marcus A Nowakowski.   

Abstract

Tulathromycin is a novel member of the triamilide class of antibiotics that was developed as a safe and effective single-dose treatment of bovine and porcine respiratory disease. An accurate and precise analytical method was developed for the extraction and measurement of tulathromycin in livestock plasma and lung homogenates. Analytes were solid-phase extracted onto a weak cation exchanger after aqueous dilution of samples and addition of heptadeutero-tulathromycin as an internal standard. Following HPLC with a narrow bore C8 column, quantitative detection of tulathromycin was accomplished by monitoring the transition of a doubly charged precursor ion to a singly charged product ion by tandem mass spectrometry using a triple quadrupole mass spectrometer. Procedures were validated for a dynamic range of 0.1 to 25 ng on column. Observed accuracies were between 90 and 110% of nominal and precision (RSD) varying 7% or less. Response and stability experiments showed that deuterated tulathromycin did not parallel the chemical behavior of tulathromycin. Applicability of the method to livestock studies was tested with plasma and lung samples from cattle and swine dosed with tulathromycin at multiple doses. The results demonstrated that the analytical method performed well in a range of sample concentrations spanning over 3 orders of magnitude and provided dose-exposure relationships for cattle and swine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15080618     DOI: 10.1021/jf0351624

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  7 in total

1.  Concentration of the macrolide antibiotic tulathromycin in broncho-alveolar cells is influenced by comedication of rifampicin in foals.

Authors:  Monica Venner; Jette Peters; Nina Höhensteiger; Birthe Schock; Alexa Bornhorst; Markus Grube; Ulrike Adam; Eberhard Scheuch; Werner Weitschies; Dieter Rosskopf; Heyo K Kroemer; Werner Siegmund
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-15       Impact factor: 3.000

2.  Caprine abscess model of tulathromycin concentrations in interstitial fluid from tissue chambers inoculated with Corynebacterium pseudotuberculosis following subcutaneous or intrachamber administration.

Authors:  K E Washburn; V R Fajt; S D Lawhon; L G Adams; L A Tell; W T Bissett
Journal:  Antimicrob Agents Chemother       Date:  2013-10-07       Impact factor: 5.191

3.  Pharmacokinetics of tulathromycin in healthy and neutropenic mice challenged intranasally with lipopolysaccharide from Escherichia coli.

Authors:  N Villarino; S A Brown; T Martín-Jiménez
Journal:  Antimicrob Agents Chemother       Date:  2012-05-14       Impact factor: 5.191

4.  Comparison of Active Drug Concentrations in the Pulmonary Epithelial Lining Fluid and Interstitial Fluid of Calves Injected with Enrofloxacin, Florfenicol, Ceftiofur, or Tulathromycin.

Authors:  Derek M Foster; Luke G Martin; Mark G Papich
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

5.  Estimation of tulathromycin depletion in plasma and milk after subcutaneous injection in lactating goats using a nonlinear mixed-effects pharmacokinetic modeling approach.

Authors:  Zhoumeng Lin; Matthew Cuneo; Joan D Rowe; Mengjie Li; Lisa A Tell; Shayna Allison; Jan Carlson; Jim E Riviere; Ronette Gehring
Journal:  BMC Vet Res       Date:  2016-11-18       Impact factor: 2.741

6.  A single LC-MS/MS validated method for tulathromycin quantification in plasma, seminal plasma, and urine to be applied in a pharmacokinetic study in bull.

Authors:  Andrea Barbarossa; Anisa Bardhi; Teresa Gazzotti; Gaetano Mari; Giampiero Pagliuca
Journal:  Drug Test Anal       Date:  2022-04-12       Impact factor: 3.234

7.  Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of tulathromycin against Haemophilus parasuis in an experimental neutropenic guinea pig model.

Authors:  Yongda Zhao; Li-Li Guo; Binghu Fang; Baotao Liu
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.